# The Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015, Regulation 5: Exception for medicines indicated for the treatment of persons aged under 18


(1) This regulation applies to the sale of a nicotine inhaling product which—
(a) is an authorised medicinal product; and
(b) is indicated for the treatment of persons of the age of the person to whom the product is sold.
(2) For the purposes of this regulation—
(a) a product is indicated for the treatment of persons of a particular age if it is described as such in the summary of the product characteristics for the product in accordance with paragraph 27 of Schedule 8 to the Human Medicines Regulations 2012 (summary of the product characteristics) ...;
(b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(c) a medicinal product is “authorised” if one of the following is in force for the product—
(i) a UK marketing authorisation; or
(ii) a parallel import licence.

---
Source: https://www.legislation.gov.uk/uksi/2015/895/regulation/5 (the official version)
Page: https://openlegislation.uk/nicotine-inhaling-products-age-of-sale-and-proxy-purchasing-regulations-2015/regulation-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

